We have seen a surge in the use of immunotherapy for the treatment of cancer. Biological response modifiers can act passively by enhancing the immunologic response to tumor cells or actively by ...
The management of rheumatoid arthritis (RA) with biological response modifiers (BRMs) is reviewed. RA, an autoimmune disorder affecting 1-2% of the world's population, is characterized by inflammation ...
Please provide your email address to receive an email when new articles are posted on . Men, along with clinicians with more than 4 years’ experience, were more likely than women and less experienced ...
(HealthDay News) — For pediatric patients, the use of biologic response modifiers (BRMs) is associated with increased risk of infectious complications, according to a clinical report published online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results